Arcalyst (rilonacept) is a prescription medication that's used to treat adults and children with certain rare inflammatory conditions, including cryopyrin-associated periodic syndromes (CAPS), deficiency of interleukin-1 receptor antagonist (DIRA), and recurrent pericarditis (RP). It's given as an injection under the skin once a week. The medication is approved for use in adults and children 12 years and older. Common side effects include injection site reactions and upper respiratory tract infections.
Treatment of cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS) and Muckle-wells Syndrome (MWS)
Maintenance of deficiency of interleukin-1 receptor antagonist (DIRA)
Treatment and prevention of recurrent pericarditis (RP)
Arcalyst (rilonacept) is an interleukin-blocker. It works by blocking interleukin-1 (IL-1), a protein in the body that causes inflammation. By stopping IL-1, Arcalyst (rilonacept) helps lower inflammation and manage symptoms of certain inflammatory conditions.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Only injected once a week
Can be used to treat adults and children
The first and only FDA-approved medication for RP
Commonly causes injection-site reactions
Carries a risk of serious infections
Must prepare the medication before using
Don't give yourself or your child Arcalyst (rilonacept) until you’ve learned how to prepare and inject it correctly. Your healthcare team will show you how to do your first dose. You can also visit this website for step-by-step instructions.
Arcalyst (rilonacept) is injected under the skin on the stomach or thighs. Avoid the area within 2 inches of your belly button. If you're giving the injection to someone else, you can also use the underside of their upper arms.
If your dose includes two injections of Arcalyst (rilonacept) on the same day, use different spots on the body. This helps avoid skin irritation.
Always inject Arcalyst (rilonacept) into skin that is clean and healthy. Don’t inject into areas that are red, bruised, sore, or hard. Change injection spots each time to protect your skin.
Only use sterile water, syringes, or needles provided by your pharmacy. Don't share or reuse needles or syringes to prevent possible infections. Throw away your supplies in a sharps container after each use.
Avoid live vaccines while taking Arcalyst (rilonacept). Talk to your healthcare team about which vaccines are safe.
Call your prescriber if you or your child get a fever, sore throat, cough, or chills while taking Arcalyst (rilonacept). These could be signs of a serious infection.
Some medications, like Enbrel (etanercept) or Humira (adalimumab), can interact with Arcalyst (rilonacept) and increase your risk of infection. Tell your care team about all the medications and supplements you take so they can make sure everything is safe to take together.
Store Arcalyst (rilonacept) in the refrigerator before mixing. Keep it in the original container to protect it from light.
After mixing Arcalyst (rilonacept) with sterile water, keep the mixture at room temperature. Make sure to use the medication within 3 hours.
Arcalyst (rilonacept) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Current, long-term, or recurrent infection | History of HIV, hepatitis B, or hepatitis C | History of asthma | History of tuberculosis (TB) | History of diabetes or other immune system problems | Taking other medications that can weaken the immune system
Arcalyst (rilonacept) can lower your body's ability to fight off infections. Serious infections — like bronchitis, TB, and meningitis, — have happened in people taking this medication. You shouldn’t take certain medications, like corticosteroids or TNF blockers, with Arcalyst (rilonacept) because they can raise your risk of serious infections.
Don't use Arcalyst (rilonacept) if you have a current infection, a long-term infection, or infections that keep coming back. This medication can make these infections worse. Call your healthcare team right away if you notice signs or symptoms of an infection like fever, cough, chills, sore throat, runny or stuffy nose, body aches, open sores, or feeling tired.
It’s not clear whether taking Arcalyst (rilonacept) can put you at risk for cancer. Some other medications that affect the immune system, like Enbrel (etanercept), have been linked to a higher risk of certain cancers. If you're worried, talk to your prescriber to see if Arcalyst (rilonacept) is the right choice for you.
Arcalyst (rilonacept) can cause your cholesterol and triglycerides (fats) levels to go up. Your prescriber might check these levels during treatment. If they're too high, they might recommend treatment to help manage your heart health.
Risk factors: Receiving live vaccines
If you’re taking Arcalyst (rilonacept), you should avoid getting live vaccines, since there’s not enough information about the risk of spreading infection. Vaccines might also not work as well while you’re taking Arcalyst (rilonacept) because it can affect how your immune system responds.
Before starting Arcalyst (rilonacept), your prescriber might recommend that you get all your routine vaccines, including the pneumococcal and inactivated flu vaccines. This helps protect you from infections before your immune system is affected by treatment.
Arcalyst (rilonacept) needs to be mixed with sterile water before injection.
Adults
CAPS and RP: The starting dose is two separate 160 mg injections given under the skin in two different spots on your body on the same day. After that, you'll inject one 160 mg injection once a week.
DIRA: The typical dose is two separate 160 mg injections given under the skin, once a week.
Children: The dose will depend on the child’s weight.
CAPS and RP (ages 12 to 17): The starting dose is 4.4 mg/kg injected under the skin. After that, your pediatrician will lower the dose to 2.2 mg/kg under the skin once a week.
DIRA (weighing at least 10 kg or 22 lbs): The typical dose is 4.4 mg/kg injected under the skin once a week.
Treatment of cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS) and Muckle-wells Syndrome (MWS)
Maintenance of deficiency of interleukin-1 receptor antagonist (DIRA)
Treatment and prevention of recurrent pericarditis (RP)
Certain types of periodic fever syndromes in adults and children
Systemic juvenile idiopathic arthritis (SJIA) in people ages 2 years and older
Gout flares in adults who can't take, or didn't respond well, to colchicine (Colcrys), NSAIDs, or oral corticosteroids
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.